期刊文献+

紫杉醇脂质体制备及体外抑制两种细胞的作用 被引量:2

Study on the Preparation and Inhibitory Effect on SKOV-3 and HUVEC Cells in vitro of Paclitaxel Liposomes
下载PDF
导出
摘要 目的:制备紫杉醇脂质体并考察体外对人卵巢癌上皮细胞(SKOV-3)和人脐静脉内皮细胞(HUVEC)两种细胞的抑制作用。方法:采用薄膜分散法制备紫杉醇脂质体,透射电镜观察脂质体的形貌,激光粒度仪测量粒径和Zeta电位,MTT法检测脂质体体外对SKOV-3和HUVEC的抑制作用。结果:制备的脂质体呈圆形或类圆形,平均粒径为54.6 nm,Zeta电位为-40.9 mv,体外释放符合Higuchi方程。体外细胞结果实验显示,紫杉醇能同时抑制肿瘤细胞和血管内皮细胞的生长。结论:紫杉醇脂质体较紫杉醇注射液(TAXOL)能更有效的抑制SKOV-3和HUVEC的生长。 Objective:To prepare paclitaxel liposomes and study the inhibitory effect on SKOV-3 and HUVEC in vitrd.Method: Paclitaxel liposomes were prepared by film dispersion method.TEM was used to observe the morphology of the liposomes,and the particle size and potential were measured by a laser particle size analyzer.MTT experiment was adopted to evaluate the inhibitory effect of paclitaxel liposomes on SKOV-3 and HUVEC cells.Result;Paclitaxel liposomes showed round or oval morphology with the average particle size of 54.6 nm and Zeta potential of -40.9 mv.In vitro drug release was conformed to a Higuchi equation.The results of in vitro experiments suggested that paclitaxel liposomes had the ability to inhibit the growth of tumor cells and vascular endothelial cells. Conclusion:Paclitaxel liposomes possess higher inhibitory effect on SKOV-3 and HUVEC than paclitaxel injections(TAXOL).
出处 《中国药师》 CAS 2013年第1期3-6,共4页 China Pharmacist
基金 2011年湖北省科技计划自然科学基金项目(编号:2011CDB019)
关键词 紫杉醇 脂质体 血管内皮细胞 Paclitaxel Liposomes Vascular endothelial cells
  • 相关文献

参考文献8

  • 1Perez Edith A. Microtubule inhibitors:Differentiating tubulin-inhibiting agents based on mechanisms of action,clinical activity,and resistance[J].Molecular Cancer Therapeutics,2009,(08):2086-2095.
  • 2Allwood MC,Marion H. The extraction of diethylhexylphthalate (DEHP) from polyvinyl chloride components of intravenous infusion containers and administration sets by paclitaxel injection[J].International Journal of Pharmaceutics,1996,(01):65-71.
  • 3Aragon-Ching JB,Madan RA,Dahut WL. Angiogenesis Inhibition in Prostate Cancer:Current Uses and Future Promises[J].Journal of Oncology,2010,(2010):1-7.
  • 4赵慧,王坚成,罗春蕾,孙启时,张强.多肽GRGDS修饰的紫杉醇长循环靶向脂质体的体外评价[J].中国新药杂志,2008,17(23):2034-2038. 被引量:10
  • 5Yuan F,Dellian M,Fukumura D. Vascular permeability in a human tumor xenograft:molecular size dependence and cutoff size[J].Cancer Research,1995,(17):3752-3756.
  • 6Moreira JN,Gaspar R,Allen Theresa M. Targeting stealth liposomes in a murine model of human small cell lung cancer[J].Biochimica Et Biophysica Acta,2001,(02):167-176.
  • 7Eddy P,Manon C,Bertrand P. Antiangiogenic activity of paclitexal is associated with its cytostatic effect,mediated by the initiation but not completion of a mitochondrial apoptotic signaling pathway[J].Mol Cancer Ther October,2004,(10):1301-1310.
  • 8Vacca A,Ribatti D,Iurlaro M. Docetaxel versus paclitaxel for antiangiogenesis[J].Journal of Hematotherapy and Stem Cell Research,2002,(01):103-118.

二级参考文献10

  • 1SAPRA P,ALLEN TM. Ligand-targeted liposomal anticancer drugs [ J ]. Prog Lipid Res,2003,42 ( 5 ) :439 - 463.
  • 2HYNES RO. Integrins: a family of cell surface receptors [ J ]. Cell, 1987,48 (4) :549 - 554.
  • 3HYNES RO. Integrins: versatility, modulation, and signaling in cell adhesion [ J ]. Cell, 1992,69 ( 1 ) : 11 - 25.
  • 4ZHANG X,XIE J,LI S,et al. The study on brain targeting of the amphotericin B liposomes [ J ]. J Drug Target, 2003,11 ( 2 ) : 117 - 122.
  • 5KOZIARA JM, LOCKMAN PR, ALLEN DD, et al. Paclitaxel nanoparticles for the potential treatment of brain tumors [ J]. J Control Release .2004.99 ( 2 ):259 - 269.
  • 6ELIAZ RE,SZOKA FC. Liposome-encapsulated doxorubicin targeted to CD44:a strategy to kill CD44-overexpressing tumor cells [ J ]. Cancer Res,2001,61 ( 6 ) :2592 - 2601.
  • 7VERONESE FM,HARRIS JM. Peptide and protein PEGylation III: advances in chemistry and clinical applications [ J ]. Adv Drug Deliv Rev ,2008,60( 1 ) : 1 - 2.
  • 8XIONG XB, MAHMUD A, ULUDA H,et al. Conjugation of Arginine-Glycine-Aspartic acid peptides to poly ( ethylene oxide) -b-poly(-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells [ J ]. Biomacromolecules, 2006,8 (3) :874 -884.
  • 9CANNISTRA SA, OTTENSMEIER C, NILOFF J, et al. Expression and function of beta 1 and alpha v beta 3 integrins in ovarian cancer[ J ]. Gynecol Oncol, 1995,58 (2) :216 - 225.
  • 10CAO Q,CAI W,LI T,et al. Combination of integrin siRNA and irradiation for breast cancer therapy [ J ]. Biochem Biophys Res Commun,2006,351 (3) :726 - 732.

共引文献9

同被引文献21

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部